BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26241673)

  • 1. A novel cytoplasmic tail motif regulates mouse corin expression on the cell surface.
    Li H; Zhang Y; Wang L; Dong N; Qi X; Wu Q
    Biochem Biophys Res Commun; 2015 Sep; 465(1):152-8. PubMed ID: 26241673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A corin variant identified in hypertensive patients that alters cytoplasmic tail and reduces cell surface expression and activity.
    Zhang Y; Li H; Zhou J; Wang A; Yang J; Wang C; Liu M; Zhou T; Zhu L; Zhang Y; Dong N; Wu Q
    Sci Rep; 2014 Dec; 4():7378. PubMed ID: 25488193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Processing of pro-atrial natriuretic peptide by corin in cardiac myocytes.
    Wu F; Yan W; Pan J; Morser J; Wu Q
    J Biol Chem; 2002 May; 277(19):16900-5. PubMed ID: 11884416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A common CORIN variant in hypertension reduces corin intracellular trafficking by exposing an inhibitory N-terminus.
    He M; Zhang Y; Li H; Liu M; Dong N; Wu Q
    Biochem Biophys Res Commun; 2020 Sep; 530(1):35-41. PubMed ID: 32828311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human corin isoforms with different cytoplasmic tails that alter cell surface targeting.
    Qi X; Jiang J; Zhu M; Wu Q
    J Biol Chem; 2011 Jun; 286(23):20963-9. PubMed ID: 21518754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of domain structures in the propeptide of corin essential for the processing of proatrial natriuretic peptide.
    Knappe S; Wu F; Madlansacay MR; Wu Q
    J Biol Chem; 2004 Aug; 279(33):34464-71. PubMed ID: 15192093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of corin protein domains required for PCSK6-mediated activation.
    Chen S; Wang H; Li H; Zhang Y; Wu Q
    Int J Biochem Cell Biol; 2018 Jan; 94():31-39. PubMed ID: 29180304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct roles of N-glycosylation at different sites of corin in cell membrane targeting and ectodomain shedding.
    Wang H; Zhou T; Peng J; Xu P; Dong N; Chen S; Wu Q
    J Biol Chem; 2015 Jan; 290(3):1654-63. PubMed ID: 25451932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of the transmembrane domain and activation cleavage of human corin: design and characterization of a soluble corin.
    Knappe S; Wu F; Masikat MR; Morser J; Wu Q
    J Biol Chem; 2003 Dec; 278(52):52363-70. PubMed ID: 14559895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corin variant associated with hypertension and cardiac hypertrophy exhibits impaired zymogen activation and natriuretic peptide processing activity.
    Wang W; Liao X; Fukuda K; Knappe S; Wu F; Dries DL; Qin J; Wu Q
    Circ Res; 2008 Aug; 103(5):502-8. PubMed ID: 18669922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corin mutation R539C from hypertensive patients impairs zymogen activation and generates an inactive alternative ectodomain fragment.
    Dong N; Fang C; Jiang Y; Zhou T; Liu M; Zhou J; Shen J; Fukuda K; Qin J; Wu Q
    J Biol Chem; 2013 Mar; 288(11):7867-7874. PubMed ID: 23372161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCSK6-mediated corin activation is essential for normal blood pressure.
    Chen S; Cao P; Dong N; Peng J; Zhang C; Wang H; Zhou T; Yang J; Zhang Y; Martelli EE; Naga Prasad SV; Miller RE; Malfait AM; Zhou Y; Wu Q
    Nat Med; 2015 Sep; 21(9):1048-53. PubMed ID: 26259032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corin is co-expressed with pro-ANP and localized on the cardiomyocyte surface in both zymogen and catalytically active forms.
    Gladysheva IP; Robinson BR; Houng AK; Kováts T; King SM
    J Mol Cell Cardiol; 2008 Jan; 44(1):131-42. PubMed ID: 17996891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corin mutations K317E and S472G from preeclamptic patients alter zymogen activation and cell surface targeting. [Corrected].
    Dong N; Zhou T; Zhang Y; Liu M; Li H; Huang X; Liu Z; Wu Y; Fukuda K; Qin J; Wu Q
    J Biol Chem; 2014 Jun; 289(25):17909-16. PubMed ID: 24828501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme.
    Yan W; Wu F; Morser J; Wu Q
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8525-9. PubMed ID: 10880574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-glycosylation modulates the cell-surface expression and catalytic activity of corin.
    Gladysheva IP; King SM; Houng AK
    Biochem Biophys Res Commun; 2008 Aug; 373(1):130-5. PubMed ID: 18549807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of the mosaic transmembrane serine protease corin to heart myocytes.
    Hooper JD; Scarman AL; Clarke BE; Normyle JF; Antalis TM
    Eur J Biochem; 2000 Dec; 267(23):6931-7. PubMed ID: 11082206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulated inositol-requiring protein 1-dependent decay as a mechanism of corin RNA and protein deficiency in advanced human systolic heart failure.
    Lee R; Xu B; Rame JE; Felkin LE; Barton P; Dries DL
    J Am Heart Assoc; 2014 Dec; 3(6):e001104. PubMed ID: 25516437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corin in clinical laboratory diagnostics.
    Dong N; Chen S; Wang W; Zhou Y; Wu Q
    Clin Chim Acta; 2012 Feb; 413(3-4):378-83. PubMed ID: 22093942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of glycosylation in corin zymogen activation.
    Liao X; Wang W; Chen S; Wu Q
    J Biol Chem; 2007 Sep; 282(38):27728-35. PubMed ID: 17660514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.